Slow cell death

Alzheimer s Disease This disease is due to the accumulation of j8-amyloid protein in the brain. The protein is believed to trigger brain degeneration through cell death of the neurons. Alzheimer s disease is characterized by loss of memory and intellectual performance, and slowness in thought. In the United States, a class of drugs called cholinesterase inhibitors is approved to treat Alzheimer s disease. Both Europe and the United States have approved a drug called memantine for treatment of Alzheimer s disease. 

There is great interest in the mechanisms of cell death since better understanding might lead to therapy that slows the rate of aging and prevents or treats human disease. Two major processes of cell death have been described, apoptosis and neaosis other alternative pathways generally are variations of these (Formigli et al, 2000 Sperandio et al, 2000 Reed, 1999). Some of the intracellular events related to these types of death have been discovered (Reed, 2000). After exposure to noxious stimuli, the balance between antiapoptotic and proapoptotic influences can result in either survival or death. Many of these variable influences and the subsequent downstream concatenated events involve oxidation, which targets cellular components such as DNA, cellular proteins and membrane phospholipids. Our laboratory and others have studied the role of the redox-active cellular constituents nitric oxide ( NO) and membrane phospholipid... 

Polyphenols and flavonoids present in red wine and grape juice, fruits and vegetables, have potent antioxidant activity, which may slow down oxidative modification of LDL, and their subsequent toxicity (Wedworth and Lynch, 1995). Phenolic compounds exert cytoprotection on vascular cultured cells by inhibiting the calcium rise and subsequent oxidized LDL-mediated cell death (Vieira et al, 1998). These compounds may play a role in the relatively low level of coronary heart disease in Prance ( Fnench Paradox ) and other Mediterranean countries (Renaud and Ruf, 1994). 

F. Role in therapy Ontak is a biologic treatment for cutaneous T-ceU lymphoma, (CTCL), a rare slow-growing form of non-Hodgkin s lymphoma. Ontak is approved to treat certain patients with advanced or recurrent CTCL, when other treatments have failed. Ontak targets cells with receptors for IL-2 on their surfaces, including malignant cells and some normal lymphocytes, resulting in cell death. Approxi-... 

Vitamin E and idebenone are also potential antioxidant treatments for Alzheimer s disease as they prevent cell death caused by glutamate and amyloid (i-protcin. Clinical trials with L-deprenyl and vitamin E are currently evaluating their ability to slow the progression of Alzheimer s disease. 

Finally, there is an increasing need to evaluate the importance of environmental toxins in the pathology of Alzheimer s disease. There has been much interest lately in the role of aluminium as a causative factor, while the studies of dementia associated with the acquired immunodeficiency syndrome have focused attention on the effects of slow viruses in causing brain cell death. 

Antimitotic drugs that target microtubules (MT) or its constituent protein tubulin are one of the most successful classes of anticancer agents discovered so far. MT are long, filamentous, tube-shaped protein polymers that are essential in all eukaryotic cells. Antimitotic agents are compounds that arrest cells in mitosis, which results in the slowing or blocking of mitosis and induction of apoptotic cell death. 

---